share_log

Alliance Global Partners Initiates Coverage On Chromocell Therapeutics With Buy Rating

Alliance Global Partners Initiates Coverage On Chromocell Therapeutics With Buy Rating

全球合作伙伴开始对Chromocell Therapeutics进行买入评级覆盖
Benzinga ·  06/18 13:28

Alliance Global Partners analyst James Molloy initiates coverage on Chromocell Therapeutics (AMEX:CHRO) with a Buy rating.

Alliance Global Partners的分析师James Molloy为Chromocell Therapeutics (美交所:CHRO) 提供买入评级的股票覆盖报告。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发